OmniAb, Inc. (OABI)
NASDAQ·Healthcare·Biotechnology
$1.41
-2.43%
Mkt Cap $221.94M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $9.00M | $8.38M | -6.97% | -$0.08 | -$0.11 | -37.50% | — | — |
| Q4 2025 Nov 4, 2025 | $5.64M | $2.24M | -60.33% | -$0.14 | -$0.14 | -2.94% | — | — |
| Q3 2025 Aug 6, 2025 | $5.64M | $3.90M | -30.95% | -$0.14 | -$0.15 | -7.14% | — | — |
| Q2 2025 May 8, 2025 | $4.49M | $4.15M | -7.45% | -$0.17 | -$0.17 | +0.00% | — | — |
| Q1 2025 Mar 18, 2025 | $6.53M | $10.80M | +65.34% | -$0.13 | -$0.12 | +7.69% | — | — |
| Q4 2024 Nov 12, 2024 | $10.13M | $4.17M | -58.81% | -$0.14 | -$0.16 | -14.29% | — | — |
| Q3 2024 Aug 8, 2024 | $5.76M | $7.61M | +32.19% | -$0.18 | -$0.13 | +27.78% | — | — |
| Q2 2024 May 9, 2024 | $5.87M | $3.80M | -35.22% | -$0.17 | -$0.19 | -11.76% | — | — |
| Q1 2024 Mar 20, 2024 | $7.46M | $4.82M | -35.38% | -$0.17 | -$0.14 | +17.65% | — | — |
| Q4 2023 Nov 9, 2023 | $10.33M | $5.48M | -46.98% | -$0.14 | -$0.16 | -14.29% | — | — |
| Q3 2023 Aug 10, 2023 | $11.91M | $6.95M | -41.68% | -$0.11 | -$0.15 | -36.36% | — | — |
| Q2 2023 May 11, 2023 | $18.98M | $16.92M | -10.84% | $0.05 | -$0.06 | -220.00% | — | — |
| Q1 2023 Mar 30, 2023 | $28.02M | $35.34M | +26.15% | $0.02 | $0.07 | +250.00% | — | — |
| Q4 2022 Nov 10, 2022 | $6.91M | $6.91M | +0.00% | -$0.04 | -$0.02 | +43.65% | — | — |
| Q3 2022 Aug 12, 2022 | — | $7.20M | — | — | -$0.09 | — | — | — |
| Q2 2022 May 20, 2022 | — | $9.62M | — | — | -$0.05 | — | — | — |
| Q1 2022 Mar 28, 2022 | — | $6.28M | — | — | -$0.00 | — | — | — |
| Q1 2022 Mar 25, 2022 | — | $21.56M | — | — | -$0.13 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | $5.58M | — | — | -$0.08 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $6.60M | — | — | -$0.00 | — | — | — |